Results 241 to 250 of about 10,935,890 (352)

A CASE OF PRIMARY CANCER OF THE FRONTAL SINUS

, 1959
Tadashi Kobayashi
openalex   +2 more sources

Multi‐omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma

Molecular Oncology, EarlyView.
Using multi‐omic characterization, we aimed to identify key regulators specific to squamous cell lung carcinoma (SqCC). SqCC‐specific differentially expressed genes were integrated with metabolics data. High expression of the creatine transporter SLC6A8, along with elevated creatine levels, appeared to be a distinct metabolic feature of SqCC.
Johan Staaf, Daniel Ehinger, Hans Brunnström, Mats Jönsson, Frida Rosengren, Marija Kotevska, Anna Karlsson, Mattias Aine, Christian Frezza, Maria Planck, Elsa Arbajian   +10 more
wiley   +1 more source

Fat mass and obesity-associated protein downregulation enhances N6-methyladenosine methylation and drives ovarian cancer progression. [PDF]

J Cell Commun Signal
Wang X, Wu D, Li C, Du X.
europepmc   +1 more source

Isolation of II-Hydroxy-etiocholanol-3(α)-one-17 from the Urine of Male Patients with Adrenal Cancer [PDF]

, 1949
ELIZABETH DINGEMANSE, L. G. Huis in 't Veld   +1 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Profile of biological aging in first primary cancers: a pan-cancer analysis of two large-scale cohorts from the UK and Hong Kong. [PDF]

BMC Med
Zhan Y, Shi R, Ruan X, Yao C, Chun TTS, Liu J, Ali S, Ma R, Huang D, Huang J, Lam ACY, Ng AT, Hu W, Na R.   +13 more
europepmc   +1 more source

Cancer statistics

Ca, 1989
N. Dubrawsky
semanticscholar   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Diagnostic value of serum DR-70 levels, a new fibrin-related biomarker, in bladder cancer patients. [PDF]

BMC Urol
Karakanlı MU, Kutlutürk EG, Polat EC, Ötünçtemur A, Merder E, Dursun M, Özcan L.   +6 more
europepmc   +1 more source

Cancer of the Uterine Cervix and Social Conditions

, 1955
Percy Stocks
openalex   +2 more sources